
Replimune Group Inc (REPL) Latest News & Updates
Explore latest REPL News and Updates
Stay updated on REPL with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in REPL
Order type
Buy in
Order amount
Est. shares
0 shares
The Motley Fool •

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
GlobeNewsWire •

GlobeNewsWire •


Zacks Investment Research •


GlobeNewsWire •

Business Wire •







GlobeNewsWire •




GlobeNewsWire •

The Motley Fool •



The Motley Fool •


GlobeNewsWire •
